1. Home
  2. ALTI vs FENC Comparison

ALTI vs FENC Comparison

Compare ALTI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

N/A

Current Price

$1.48

Market Cap

334.9M

Sector

Finance

ML Signal

N/A

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

N/A

Current Price

$12.94

Market Cap

470.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALTI
FENC
Founded
2020
1996
Country
United States
United States
Employees
490
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.9M
470.6M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
ALTI
FENC
Price
$1.48
$12.94
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $17.60
AVG Volume (30 Days)
★ 287.8K
255.2K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.11
N/A
EPS
N/A
★ 0.19
Revenue
★ $254,956,000.00
$44,642,000.00
Revenue This Year
$17.39
$67.04
Revenue Next Year
$9.19
$44.54
P/E Ratio
★ N/A
$70.79
Revenue Growth
★ 23.21
N/A
52 Week Low
$1.25
$5.65
52 Week High
$5.45
$13.85

Technical Indicators

Market Signals
Indicator
ALTI
FENC
Relative Strength Index (RSI) 30.50 62.70
Support Level $1.25 $9.58
Resistance Level $3.97 $12.79
Average True Range (ATR) 0.29 0.92
MACD -0.06 0.31
Stochastic Oscillator 12.17 77.10

Price Performance

Historical Comparison
ALTI
FENC

About ALTI AlTi Global Inc.

AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: